Latest Capital Raisings News

Tamboran Resources is poised to deliver first gas sales from its Beetaloo Basin pilot project, backed by a robust balance sheet and strategic partnerships aiming to slash drilling costs.

CurveBeam AI’s FY2026 results show a 28% revenue decline and a 12% increase in net loss, while advancing its China commercialisation and robotic surgery integration strategies. The company also announced a $6-7 million capital raise post-year-end.

Xamble Group boosted revenue by 16% in the first half of FY2026, with a record Q2 performance driving a positive underlying EBITDA and sharply reduced losses.

Novatti has swung to a positive EBITDA of $2.0 million in FY26, driven by strategic refocusing on its core Payments AU/NZ business despite a 40.7% revenue decline and loss of control over AUDC.

Critical Resources Limited has secured $1.6 million through a share placement to fund exploration across multiple jurisdictions and advance early-stage battery and thermal management technologies.

Alpha HPA Limited reported a 135% revenue increase but a 31% rise in net loss for FY2026, while progressing its Stage Two facility on schedule with robust customer demand exceeding 12,000 tonnes per annum under letters of intent.

Lindian Resources has secured exclusive rights to over 13,000 tonnes of heavy rare earth feedstock in Kazakhstan, aiming to boost output at its wholly owned SARECO processing facility with dysprosium, terbium, and yttrium-rich material.

Genetic Technologies Limited slashed its net loss by nearly 88% in FY2025 following a Deed of Company Arrangement and exit from voluntary administration, pivoting to a corporate office model after selling its operating businesses.

BluGlass Limited reported a 5% reduction in its net loss to A$10.39 million for FY26 despite a 10% revenue dip, boosted by new US defence and industry contracts and a significant capital raise to fund growth.

Nexsen Limited (ASX:NXN) reported a 30% rise in net loss to $6.55 million for FY26, driven by ongoing investment in its Group B Streptococcus rapid diagnostic and Asia-Pacific growth initiatives following its October 2025 IPO.

Vectus Biosystems has reported a striking turnaround with a $1.56 million profit for the 2026 financial year, reversing a prior year loss and improving its balance sheet significantly.

Provaris Energy reported a $4.045 million loss for FY2026 as it progressed proprietary hydrogen and liquid CO₂ storage technologies, expanded strategic partnerships, and boosted cash reserves through multiple placements.